UPDATE 1-Novartis signs $170M immuno-oncology pact with Surface
January 11, 2016 at 13:15 PM EST
ZURICH, Jan 11 (Reuters) - Novartis AG has struck a $170 million alliance with U.S.-based Surface Oncology as it seeks to boost its portfolio of medicines that help the body's immune system fight cancer.
